Opioid blockers may shed light on low testosterone mystery
NCT ID NCT04975334
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a drug that blocks opioids (naloxone) affects hormone signals in the brain related to testosterone. 23 men with a condition called hypogonadotropic hypogonadism (low testosterone) took part. The goal was to understand the body's hormone control, not to treat the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOGONADOTROPIC HYPOGONADISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple supplement revive sperm health and testosterone?
- Scientists hunt for genes that control puberty
- Can acne drug or hormone shots help men with low sperm count?
- Could a weekly pill boost sperm count? new trial seeks answers
- Could a natural hormone restart periods in women with hypothalamic amenorrhea?
- Could a brain hormone fix low sex hormones? small study hints at possibility